Thomas Martin
MD
Clinical Professor of Medicine
👥Biography 个人简介
Thomas Martin is a myeloma specialist who has led clinical trials of elranatamab and other BCMA-targeting bispecific antibodies. His work on subcutaneous delivery and step-up dosing optimization has improved the convenience and safety of bispecific therapy. He has contributed to retreatment strategies for patients progressing after initial bispecific response.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Thomas Martin 的研究动态
Follow Thomas Martin's research updates
留下邮箱，当我们发布与 Thomas Martin（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment